MYL1 and ischemia: Activated MMP-2 degrades susceptible sarcomeric and cytoskeletal proteins including troponin I (TnI), myosin light chain-1 (MLC-1), and α-actin, leading to the acute contractile dysfunction observed in ischemia/reperfusion injury [32].